These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1959947)

  • 1. Circulating interferon-alpha in patients with Kyasanur forest disease.
    Sathe PS; Dandawate CN; Sharadamma K; Ghosh SN
    Indian J Med Res; 1991 Jul; 93():199-201. PubMed ID: 1959947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kyasanur forest disease: an epidemiological view in India.
    Pattnaik P
    Rev Med Virol; 2006; 16(3):151-65. PubMed ID: 16710839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Rousettus leschenaulti to infection with Kyasanur forest disease virus--a note.
    Sreenivasan MA; Bhat HR; Naik SV; Banerjee K
    Indian J Med Res; 1979 Apr; 69():535-7. PubMed ID: 222671
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistence of humoral immunity in Kyasanur forest disease.
    Achar TR; Patil AP; Jayadevaiah MS
    Indian J Med Res; 1981 Jan; 73():1-3. PubMed ID: 6263796
    [No Abstract]   [Full Text] [Related]  

  • 5. Reaction of Rattus rattus wroughtoni to Kyasanur forest disease virus.
    Goverdhan MK; Anderson CR
    Indian J Med Res; 1978 Jan; 67():5-10. PubMed ID: 207642
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of common giant flying squirrel to experimental infection with KFD virus.
    Bhat HR; Sreenivasan MA; Naik SV
    Indian J Med Res; 1979 May; 69():697-700. PubMed ID: 229076
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme linked immunosorbent assay (ELISA) using beta-lactamase for the detection of antibodies to KFD virus.
    Geetha PB; Ghosh SN; Gupta NP; Shaikh BH; Dandawate CN
    Indian J Med Res; 1980 Mar; 71():329-32. PubMed ID: 6248460
    [No Abstract]   [Full Text] [Related]  

  • 8. The reaction of Funambulus tristriatus tristriatus Rattus blanfordi and Suncus murinus to Kyasanur forest disease virus.
    Goverdhan MK; Anderson CR
    Indian J Med Res; 1981 Aug; 74():141-6. PubMed ID: 6273309
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of viruria in Kyasanur Forest disease patients.
    Benerjee K; Bhat HR
    Acta Virol; 1977 Mar; 21(2):174. PubMed ID: 17291
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of Kyasanur forest disease by nested RT-PCR, real-time RT-PCR and IgM capture ELISA.
    Mourya DT; Yadav PD; Mehla R; Barde PV; Yergolkar PN; Kumar SR; Thakare JP; Mishra AC
    J Virol Methods; 2012 Dec; 186(1-2):49-54. PubMed ID: 22874757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of serum interferon-alpha by dissociation-enhanced lanthanide fluoroimmunoassay. Studies of patients with acute viral and bacterial infections.
    Rönnblom LE; Perers A; Vallin HS; Eriksson I; Osterlind A; Cederblad B; Alm G
    APMIS; 1997 Jul; 105(7):531-6. PubMed ID: 9269299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Lepus nigricollis Cuvier, to experimental infection with Kyasanur Forest Disease virus.
    Sreenivasan MA; Bhat HR
    Indian J Med Res; 1977 Jan; 65(1):17-20. PubMed ID: 193782
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics of human infection with Kyasanur Forest Disease Virus.
    Devadiga S; Arunkumar G
    J Infect; 2022 Aug; 85(2):161-166. PubMed ID: 35609707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis.
    Kakumu S; Fuji A; Yoshioka K; Tahara H
    Hepatogastroenterology; 1989 Apr; 36(2):97-102. PubMed ID: 2499528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An outbreak of Kyasanur forest disease in the Wayanad and Malappuram districts of Kerala, India.
    Sadanandane C; Elango A; Marja N; Sasidharan PV; Raju KHK; Jambulingam P
    Ticks Tick Borne Dis; 2017 Jan; 8(1):25-30. PubMed ID: 27692988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an antiviral effect and interferon neutralizing capacity in human sera; variability and implications for HIV infection.
    Fall LS; Chams V; Le Coq H; Fouchard M; M'Bika JP; Gringeri A; Santagostino E; Bizzini B
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):409-16. PubMed ID: 7580835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease.
    Pavri K
    Rev Infect Dis; 1989; 11 Suppl 4():S854-9. PubMed ID: 2665018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Study of Kyasanur Forest Disease and Deaths among Nonhuman Primates, India, 1957-2020.
    Chakraborty S; Sander WE; Allan BF; Andrade FCD
    Emerg Infect Dis; 2021 Jul; 27(7):1969-1973. PubMed ID: 34152964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
    Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
    Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.